| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |